Cite
Successful erlotinib rechallenge for leptomeningeal metastases of lung adenocarcinoma after erlotinib-induced interstitial lung disease: A case report and review of the literature
MLA
Togashi, Yosuke, et al. “Successful Erlotinib Rechallenge for Leptomeningeal Metastases of Lung Adenocarcinoma after Erlotinib-Induced Interstitial Lung Disease: A Case Report and Review of the Literature.” Lung Cancer (01695002), vol. 77, no. 2, Aug. 2012, pp. 464–68. EBSCOhost, https://doi.org/10.1016/j.lungcan.2012.04.013.
APA
Togashi, Y., Masago, K., Hamatani, Y., Sakamori, Y., Nagai, H., Kim, Y. H., & Mishima, M. (2012). Successful erlotinib rechallenge for leptomeningeal metastases of lung adenocarcinoma after erlotinib-induced interstitial lung disease: A case report and review of the literature. Lung Cancer (01695002), 77(2), 464–468. https://doi.org/10.1016/j.lungcan.2012.04.013
Chicago
Togashi, Yosuke, Katsuhiro Masago, Yasuhiro Hamatani, Yuichi Sakamori, Hiroki Nagai, Young Hak Kim, and Michiaki Mishima. 2012. “Successful Erlotinib Rechallenge for Leptomeningeal Metastases of Lung Adenocarcinoma after Erlotinib-Induced Interstitial Lung Disease: A Case Report and Review of the Literature.” Lung Cancer (01695002) 77 (2): 464–68. doi:10.1016/j.lungcan.2012.04.013.